Selected aspects of genetic counselling for BRCA1 mutation carriers

被引:0
|
作者
Jacek Gronwald
机构
[1] Department of Genetics and Pathology,International Hereditary Cancer Center
来源
Hereditary Cancer in Clinical Practice | / 5卷
关键词
breast cancer; ovarian cancer; risk factors;
D O I
暂无
中图分类号
学科分类号
摘要
This work consists of six parts based on seven manuscripts dealing with some aspects of genetic counselling for BRCA1 mutation carriers. It was demonstrated that the risk of breast and ovarian cancer in first-degree relatives of BRCA1 mutation carriers depends on the type of mutation and is higher in the younger generation. It was also shown that risk of breast cancer, but not of ovarian cancer, is related to cancer type of the proband. These factors should be taken into account when assessing risk of breast and ovarian cancer in relatives of BRCA1 mutation carriers. It was observed that longer breast-feeding, physical activities delaying menarche, preventive oophorectomy, administration of tamoxifen to patients with intact genital tract, and use of contraceptives reduce the risk of breast and ovarian cancer. All these possibilities should be presented to BRCA1 mutation carriers within the framework of cancer risk reduction options. It was also observed that there may be some preference in transmission of the mutant allele to female offspring of BRCA1 founder mutation carriers. Environmental factors appear also to interfere with transmission. The male to female ratio in offspring of BRCA1 mutation carriers is the same as for the general population. As for the consequences of simplified two-stage genetic counselling, the first psychological reaction of a female to the fact that she is a carrier of the BRCA1 mutation is negative. However, understanding that the risk of cancer is high persuades the woman to embrace preventive options. 98% of BRCA1 mutation carriers disclosed during population screening initiated and promoted by the media are convinced of the value of genetic testing. Simplified two-stage genetic counselling appears to be a useful approach promoting increased turnout for BRCA1 mutation testing.
引用
收藏
相关论文
共 50 条
  • [41] Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers
    Leendert H Zaaijer
    Helena C van Doorn
    Marian J E Mourits
    Marc van Beurden
    Joanne A de Hullu
    Muriel A Adank
    Luc R C W van Lonkhuijzen
    Hans F A Vasen
    Brigitte F M Slangen
    Katja N Gaarenstroom
    Ronald P Zweemer
    Peggy M L H Vencken
    Caroline Seynaeve
    Mieke Kriege
    British Journal of Cancer, 2016, 115 : 1174 - 1178
  • [42] Body weight and risk of breast cancer in BRCA1/2 mutation carriers
    Manders, Peggy
    Pijpe, Anouk
    Hooning, Maartje J.
    Kluijt, Irma
    Vasen, Hans F. A.
    Hoogerbrugge, Nicoline
    van Asperen, Christi J.
    Meijers-Heijboer, Hanne
    Ausems, Margreet G. E. M.
    van Os, Theo A.
    Gomez-Garcia, Encarna B.
    Brohet, Richard M.
    van Leeuwen, Flora E.
    Rookus, Matti A.
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 126 (01) : 193 - 202
  • [43] Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers
    Zaaijer, Leendert H.
    van Doorn, Helena C.
    Mourits, Marian J. E.
    van Beurden, Marc
    de Hullu, Joanne A.
    Adank, Muriel A.
    van Lonkhuijzen, Luc R. C. W.
    Vasen, Hans F. A.
    Slangen, Brigitte F. M.
    Gaarenstroom, Katja N.
    Zweemer, Ronald P.
    Vencken, Peggy M. L. H.
    Seynaeve, Caroline
    Kriege, Mieke
    BRITISH JOURNAL OF CANCER, 2016, 115 (10) : 1174 - 1178
  • [44] Survival in Norwegian BRCA1 mutation carriers with breast cancer
    Hagen, Anne Irene
    Tretli, Steinar
    Maehle, Lovise
    Apold, Jaran
    Veda, Nina
    Moller, Pal
    HEREDITARY CANCER IN CLINICAL PRACTICE, 2009, 7
  • [45] Tamoxifen and the risk of ovarian cancer in BRCA1 mutation carriers
    Vicus, Danielle
    Rosen, Barry
    Lubinski, Jan
    Domchek, Susan
    Kauff, Noah D.
    Lynch, Henry T.
    Isaacs, Claudine
    Tung, Nadine
    Sun, Ping
    Narod, Steven A.
    GYNECOLOGIC ONCOLOGY, 2009, 115 (01) : 135 - 137
  • [46] International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers
    Metcalfe, Kelly A.
    Birenbaum-Carmeli, Daphna
    Lubinski, Jan
    Gronwald, Jacek
    Lynch, Henry
    Moller, Pal
    Ghadirian, Parviz
    Foulkes, William D.
    Klijn, Jan
    Friedman, Eitan
    Kim-Sing, Charmaine
    Ainsworth, Peter
    Rosen, Barry
    Domchek, Susan
    Wagner, Teresa
    Tung, Nadine
    Manoukian, Siranoush
    Couch, Fergus
    Sun, Ping
    Narod, Steven A.
    INTERNATIONAL JOURNAL OF CANCER, 2008, 122 (09) : 2017 - 2022
  • [47] Uptake of genetic counseling among adult children of BRCA1/2 mutation carriers in France
    Cristaldo, Fatima Belen Gauna
    Touzani, Rajae
    Apostolidis, Thernis
    Mouret-Fourme, Emmanuelle
    Stoppa-Lyonnet, Dominique
    Lasset, Christine
    Fricker, Jean-Pierre
    Berthet, Pascaline
    Julian-Reynier, Claire
    Mancini, Julien
    Nogues, Catherine
    Bouhnik, Anne-Deborah
    PSYCHO-ONCOLOGY, 2019, 28 (09) : 1894 - 1900
  • [48] Factors influencing ovulation and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers
    Kotsopoulos, Joanne
    Lubinski, Jan
    Gronwald, Jacek
    Cybulski, Cezary
    Demsky, Rochelle
    Neuhausen, Susan L.
    Kim-Sing, Charmaine
    Tung, Nadine
    Friedman, Susan
    Senter, Leigha
    Weitzel, Jeffrey
    Karlan, Beth
    Moller, Pal
    Sun, Ping
    Narod, Steven A.
    INTERNATIONAL JOURNAL OF CANCER, 2015, 137 (05) : 1136 - 1146
  • [49] Rates of risk-reducing surgery in Israeli BRCA1 and BRCA2 mutation carriers
    Laitman, Y.
    Vaisman, Y.
    Feldman, D.
    Helpman, L.
    Gitly, M.
    Shimon, S. Paluch
    Berger, R.
    Cohen, L.
    Narod, S. A.
    Friedman, E.
    CLINICAL GENETICS, 2014, 85 (01) : 68 - 71
  • [50] An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA)
    Georgia Chenevix-Trench
    Roger L Milne
    Antonis C Antoniou
    Fergus J Couch
    Douglas F Easton
    David E Goldgar
    Breast Cancer Research, 9